These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3931414)

  • 1. [In vitro pharmaceutical control of pharmaceutical preparations. 4. Comparative dissolution and in vitro equivalence study of nitroglycerin tablets].
    Keserü P; Paál T; Török I; Köszeginé Szalai H; Kissné Csikós E
    Acta Pharm Hung; 1985 Jul; 55(4):229-37. PubMed ID: 3931414
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study on dissolution in vitro of Zhike Pingchuan sustained-release tablets].
    Li X; Feng Z; Huo W; Li Y; Wang B; Zhu S
    Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1216-9. PubMed ID: 19673379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation.
    Fahmy RH; Kassem MA
    Eur J Pharm Biopharm; 2008 Aug; 69(3):993-1003. PubMed ID: 18396390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of dissolution tests for fexofenadine hydrochloride capsules and coated tablets.
    Breier AR; Paim CS; Steppe M; Schapoval EE
    J Pharm Pharm Sci; 2005 Aug; 8(2):289-98. PubMed ID: 16124939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro dissolution test of tamoxifen citrate preparations.
    Braga RM; Carvalho RD; Fonseca SG; Strattmann R; De Santana DP; De Albuquerque MM
    Boll Chim Farm; 2001; 140(6):467-70. PubMed ID: 11822241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lisinopril and lisinopril/hydrochlorothiazide preparations on the Belgian market: a comparative study.
    De Braekeleer K; Corthout J
    J Pharm Belg; 2008 Sep; 63(3):78-83. PubMed ID: 18972864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of ketoprofen bioavailability by formation of microsponge tablets.
    Comoglu T; Savaşer A; Ozkan Y; Gönül N; Baykara T
    Pharmazie; 2007 Jan; 62(1):51-4. PubMed ID: 17294814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of an oral nitroglycerin proxyphyllin retard compound].
    Ritschel WA; Clotten R
    Arzneimittelforschung; 1970 Sep; 20(9):1180-7. PubMed ID: 4992053
    [No Abstract]   [Full Text] [Related]  

  • 11. Sublingual nitroglycerin. II. In vitro and in vivo availability of Nitrostat and Nitrobaat tablets.
    Lagas M; Duchateau AM
    Pharm Weekbl Sci; 1988 Dec; 10(6):254-8. PubMed ID: 3145488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the pharmaceutical quality of some quinine preparations sold in Nigeria.
    Nnamdi JA; Arhewoh IM; Okhamafe AO; Enato EF
    Med Princ Pract; 2009; 18(3):193-7. PubMed ID: 19349721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro biopharmaceutical control of pharmaceutical preparations. 7. Design and experimental study of flow through cells applicable to dissolution tests].
    Kissné Csikós E; Keserü P
    Acta Pharm Hung; 1986 Jan; 56(1):26-33. PubMed ID: 3953284
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparative study of dissolution characteristics of polymeric and wax granulations of theophylline and their tablets.
    Uhumwangho MU; Okor RS
    Pak J Pharm Sci; 2008 Jul; 21(3):230-6. PubMed ID: 18614417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biorelevant dissolution media as a predictive tool for glyburide a class II drug.
    Wei H; Löbenberg R
    Eur J Pharm Sci; 2006 Sep; 29(1):45-52. PubMed ID: 16815694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluconazole preparations on the Belgian market: a comparative study.
    De Braekeleer K; Fierens C; Corthout J
    J Pharm Belg; 2006; 61(4):111-6. PubMed ID: 17263192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmaceutical and biological availability of commercial preparations of furosemide.
    Stüber W; Mutschler E; Steinbach D
    Arzneimittelforschung; 1982; 32(6):693-7. PubMed ID: 6889429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propranolol preparations on the Belgian market: a comparative study.
    De Braekeleer K; Fierens C; Corthout J
    J Pharm Belg; 2007; 62(3):80-4. PubMed ID: 17955956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissolution test for citalopram in tablets and comparison of in vitro dissolution profiles.
    Menegola J; Steppe M; Schapoval EE
    Eur J Pharm Biopharm; 2007 Sep; 67(2):524-30. PubMed ID: 17398084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simple and reliable HPLC analysis of fexofenadine hydrochloride in tablets and its application to dissolution studies.
    Oliveira DC; Weigch A; Rolim CM
    Pharmazie; 2007 Feb; 62(2):96-100. PubMed ID: 17341026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.